Stocks Johnson & Johnson

More

  • graphic_word_ofthe_street.jpg

    Fearing the two largest U.S. mortgage finance companies need a government bailout, investors pushed stocks lower Friday. What's the "Word On The Street?"

  • 080519 contest.jpg

    Nearly 1.4 billion shares and over $16 billion traded yesterday in CNBC's Million Dollar Portfolio Challenge.  Check out the bets being made today...

  • Former Citigroup Chairman and Chief Executive Chuck Prince has joined the Xerox board of directors, Xerox said on Thursday.

  • It's a booyah-free zone. There goes Swifty!

  • graphic_word_ofthe_street.jpg

    The S&P closed 20% below its all-time high set in October, making it the last of the three major U.S. stock indexes to fall into a bear market. What's the "Word on the Street?"

  • earnings_central.jpg

    Wall Street is bracing for a big round of second-quarter earnings reports that few expect to deliver good news for the state of corporate America.

  • cadeuses2.jpg

    In the world of nearly 400 publicly-traded biotechs, analyst coverage is especially important. Many of the firms are micro caps and when an analyst initiates coverage it can help put a baby biotech on investor and reporter radar screens.

  • Fourth of July fireworks

    FBR's Christopher Warren is out with a research note to clients this morning saying that Boston Scientific is doing deals. He writes that BSX is "reportedly bundling $1,100 (that's right, $1,100) Taxus stents with defibrillators and ultrasound devices."

  • Vince Farrell

    I had a visit on Power Lunch today and we talked about the effect on the health care stocks depending on who wins the White House. In general, pharmaceutical companies do well when they have a new product pipeline of innovative products that allow them to command high prices.

  • The week began with a flashback to the credit crisis.  It ended with figures showing the fastest inflation in six months and the lowest consumer-sentiment reading in 28 years.  Along the way, as the stock market ebbed and flowed, CNBC guests assembled a collective portfolio that was heavy on technology, energy, and global exposure.

  • CNBC asked the market experts where investors should be putting their money, and here are some of their best suggestions.

  • Robert Zagunis says investors should put their money into shares of diversified international companies: "where the action is."

  • Oil dominated the news again during the week, though crude prices fell back for a change. Economic data also moved the markets, which finished up for the week.

  • Stocks moved higher on positive earnings in technology and a report that inflation appeared to be moderating.

  • Sometimes a deal from hell can become one hell of a deal. Following are three takeover stories that could be worth a trade.

  • After last week's massive tumble in the Dow, Dan Genter of RNC Genter Capital Management and Jill Evans of Alpine Funds say a company's dividends deserve as much attention -- at least -- as total returns.

  • After last week's massive tumble in the Dow, Dan Genter of RNC Genter Capital Management and Jill Evans of Alpine Funds say a company's dividends deserve as much attention -- at least -- as total returns.

  • 2008 Olympics Beijing

    Michael Maslansky of Luntz, Maslansky Strategic Research just went on the air with me. His company polled 1,000 people online and asked them various questions about the Olympics. Here is the most important question. How much more or less likely are you to buy a product...

  • Johnson & Johnson

    Two cardiologists write in "The New England Journal of Medicine" that Johnson and Johnson's first-of-its kind TV commercial for a heart stent is aimed at "millions of people who are ill-equipped to make judgments" about the device.

  • Heart Stent

    Too few influential doctors are telling the public if they have financial ties to the companies that make lifesaving drug-coated stents.